XBiotech, Inc. (XBIT)
2.18
+0.03
(+1.40%)
USD |
NASDAQ |
Sep 29, 16:00
2.17
-0.01
(-0.46%)
Pre-Market: 20:00
XBiotech Price to Book Value : 0.5174 for Sept. 29, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 0.5174 |
| September 28, 2026 | 0.5103 |
| September 25, 2026 | 0.515 |
| September 24, 2026 | 0.5126 |
| September 23, 2026 | 0.5174 |
| September 22, 2026 | 0.5174 |
| September 21, 2026 | 0.5174 |
| September 18, 2026 | 0.5198 |
| September 17, 2026 | 0.5174 |
| September 16, 2026 | 0.5103 |
| September 15, 2026 | 0.5209 |
| September 14, 2026 | 0.515 |
| September 11, 2026 | 0.5198 |
| September 10, 2026 | 0.515 |
| September 09, 2026 | 0.5174 |
| September 08, 2026 | 0.5174 |
| September 04, 2026 | 0.5221 |
| September 03, 2026 | 0.5221 |
| September 02, 2026 | 0.5198 |
| September 01, 2026 | 0.5269 |
| August 31, 2026 | 0.5459 |
| August 28, 2026 | 0.5387 |
| August 27, 2026 | 0.5459 |
| August 26, 2026 | 0.5482 |
| August 25, 2026 | 0.5459 |
| Date | Value |
|---|---|
| August 24, 2026 | 0.5482 |
| August 21, 2026 | 0.5411 |
| August 20, 2026 | 0.5482 |
| August 19, 2026 | 0.5482 |
| August 18, 2026 | 0.5387 |
| August 17, 2026 | 0.5482 |
| August 14, 2026 | 0.5459 |
| August 13, 2026 | 0.553 |
| August 12, 2026 | 0.5838 |
| August 11, 2026 | 0.553 |
| August 10, 2026 | 0.5411 |
| August 07, 2026 | 0.5387 |
| August 06, 2026 | 0.5411 |
| August 05, 2026 | 0.5364 |
| August 04, 2026 | 0.5316 |
| August 03, 2026 | 0.5304 |
| July 31, 2026 | 0.5292 |
| July 30, 2026 | 0.5316 |
| July 29, 2026 | 0.534 |
| July 28, 2026 | 0.5387 |
| July 27, 2026 | 0.5364 |
| July 24, 2026 | 0.5387 |
| July 23, 2026 | 0.5411 |
| July 22, 2026 | 0.5387 |
| July 21, 2026 | 0.5316 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.664 |
| Alnylam Pharmaceuticals, Inc. | 25.09 |
| Anika Therapeutics, Inc. | 1.944 |
| Savara, Inc. | 7.263 |
| Vericel Corp. | 5.616 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0244 |
| Price | 2.18 |
| Earnings Yield | -67.91% |
| Market Cap | 66.46M |
| PEGY Ratio | -0.0244 |